## Scientific objective

For benzothiazole and (1-methyl-1H-imidazol-2-yl)(3-phenylbicyclo[1.1.0]butan-1-yl)methanone under the specified Ni(OTf)2 and chiral PyBOX conditions in chloroform, why does the cycloadduct with the constitutional structure specified below form, and which enantiomeric preference is expected? Develop and test a computational explanation of the observed product formation and enantioselectivity.

## Public inputs and scientific boundaries

Use `data/inputs/system.json` as the complete starting specification:
- PI1 defines the two organic reactants, including the bicyclobutane bridgehead substituents.
- PI2 defines nickel(II) triflate and the exact chiral tert-butyl PyBOX ligand, including both S stereocenters.
- PI3 supplies the reaction amounts, catalyst and ligand loadings, solvent, temperature, atmosphere and duration.
- PI4 supplies the observed constitutional product, an explicit connectivity description, NMR yield and an enantiomeric ratio without assigning the major absolute configuration.

Investigate this specified transformation and catalyst/ligand pair. Explain product formation and enantiomeric preference together, not a single isolated energy, structure or descriptor. The supplied product connectivity is an observation to explain, not a hidden structure to guess. The yield is experimental context, not a mandatory computational yield prediction. Other substrates, alternative ligand catalogues and downstream synthetic transformations are outside the requested outcomes. Choose and justify molecular models from the defined identities; no starting geometry or catalyst coordination model is prescribed. State how any approximations limit inference about the specified reaction conditions.

## Required investigation

Develop testable explanations of product formation and enantiomeric preference, choose informative computational investigations, and actually execute research. Build a chemically meaningful account connecting the defined reactants to the supplied product and explain the role of the specified catalyst/ligand system in that account. Predict the major enantiomer with an unambiguous mapping to the saturated CH identified in PI4, and investigate what makes the enantiomer-forming possibilities differ. Relate the supported preference and its strength to the supplied experimental ratio without treating a model-dependent quantity as an exact experimental measurement.

Choose the hypotheses, models, physical effects and informative tests yourself. Explain what each investigation can establish, preserve actual inputs, outputs and logs, check reliability, and use the resulting evidence to retain, revise or reject your explanations. No fixed number of hypotheses, tests, conformers or pathways is required; an exhaustive network or a particular explanatory descriptor is not demanded. Both the product-forming account and the origin of selectivity remain scientific outcomes even when a supporting analysis is optional.

Validation requirements follow the claims made. Transition-state assignments require appropriate vibrational characterization and evidence of the chemical connections claimed. Claims about rates or a kinetic model require the relevant equations, observation mapping and a defensible assessment of identifiability. Charge, orbital, geometry or interaction observations alone must not be presented as measured barriers or proof of a unique mechanism. Distinguish observations, computational results and interpretations, including relevant limitations of the model and evidence.

If an author-provided scientific guidance block is supplied, execute and assess that disclosed baseline for this same question, recording protocol fidelity, ambiguities and justified substitutions in the investigations and readable report. If no such block is supplied, select the research approach independently; there is no obligation to follow an undisclosed method or explanation.

## Deliverables and stopping conditions

Follow `submission_schema.json` and `submission_guide.md`. Submit:
- `report/results.json`: the canonical structured submission with linked hypotheses, investigations, evidence, conclusions, limitations and reproducibility records.
- `report/report.md`: a readable scientific account of the actual work, product-forming explanation, mapped enantiomeric prediction, evidence-based decisions, uncertainty and actual resource use.
- `research/`: the actual computational inputs, outputs, logs and analysis code referenced by the submission.

Stop when the evidence supports the conclusions you claim and remaining uncertainty is stated. Research completion is different from question resolution: use the guide’s separate research and question statuses. Honest partial investigations or execution failure are acceptable with attempted inputs, real logs and explicit limits; do not fabricate unavailable results. Careful research may leave the question unresolved. Agreement with a reference alone is insufficient, and an unresolved label never earns automatic question-resolution credit. The shared evaluation allocates 60 points to research quality and 40 to the evidence-supported scientific outcomes, with credit for established partial outcomes and defensible alternatives. No fixed CPU, GPU, memory, walltime or job-count quota is imposed.
